These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Ghilardi G; Biondi ML; Mangoni J; Leviti S; DeMonti M; Guagnellini E; Scorza R Clin Cancer Res; 2001 Aug; 7(8):2344-6. PubMed ID: 11489811 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845 [TBL] [Abstract][Full Text] [Related]
5. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653 [TBL] [Abstract][Full Text] [Related]
6. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595 [TBL] [Abstract][Full Text] [Related]
7. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. Woo M; Park K; Nam J; Kim JC J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852 [TBL] [Abstract][Full Text] [Related]
8. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]. Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933 [TBL] [Abstract][Full Text] [Related]
9. No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese. Xu E; Lai M; Lŭ B; Xing X; Huang Q Dis Colon Rectum; 2006 Sep; 49(9):1439-44. PubMed ID: 16937230 [TBL] [Abstract][Full Text] [Related]
10. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population. Kouhkan F; Motovali-Bashi M; Hojati Z Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818 [TBL] [Abstract][Full Text] [Related]
12. A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer. Shin Y; Kim IJ; Kang HC; Park JH; Park HW; Jang SG; Lee MR; Jeong SY; Chang HJ; Ku JL; Park JG Carcinogenesis; 2004 Nov; 25(11):2173-6. PubMed ID: 15231691 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer. Decock J; Paridaens R; Ye S Clin Genet; 2008 Mar; 73(3):197-211. PubMed ID: 18177467 [TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. Astolfi CM; Shinohara AL; da Silva RA; Santos MC; Line SR; de Souza AP J Clin Periodontol; 2006 Oct; 33(10):699-703. PubMed ID: 16899023 [TBL] [Abstract][Full Text] [Related]
15. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population. Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848 [TBL] [Abstract][Full Text] [Related]
16. Genetic patterns of metalloproteinases and their tissular inhibitors - clinicopathologic and prognostic significance in colorectal cancer. Surlin V; Ioana M; Pleşea IE Rom J Morphol Embryol; 2011; 52(1 Suppl):231-6. PubMed ID: 21424059 [TBL] [Abstract][Full Text] [Related]
17. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease. Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population. Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population. Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856 [TBL] [Abstract][Full Text] [Related]
20. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]